IDIDEXX Laboratories IDXX · NASDAQ
$560.36 +2.41% (+$13.18)
- Market cap
- $43.1B
- Enterprise value
- $44.0B
- P/E
- 37.8x
- Forward P/E
- 36.2x
- PEG
- 2.1x
- P/S
- 9.5x
- P/FCF
- 34.5x
- EV/EBITDA
- 27.2x
- ROIC
- 40.9%
- Gross margin
- 62.4%
- Net margin
- 25.0%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 0.6x
- Beta
- 1.55
- Free float
- 99.6%
About the company
IDEXX Laboratories, Inc. (IDXX) is an American company specializing in the development and manufacturing of diagnostic tests for veterinary care. With a portfolio of innovative diagnostic products, laboratory tests, and software solutions, IDEXX Laboratories provides essential support to veterinarians and veterinary laboratories. The company is known for its technologically advanced methods of animal diagnostics, enabling rapid and accurate determination of diseases and the overall health status of animals.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Michael Erickson
Employees
11,000
Headquarters
Westbrook
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number